fbpx
Shop on Aqila.NG


ITEL OFFICIAL STORE
NewsHealthWorld News

Russian President Putin Announces Progress Towards Launching Cancer Vaccines

16
×

Russian President Putin Announces Progress Towards Launching Cancer Vaccines

Share this article
Russian President Putin Announces Progress Towards Launching Cancer Vaccines

During a Moscow forum on future technologies, President Vladimir Putin revealed that Russian scientists are on the brink of launching vaccines for cancer, a significant development that could soon benefit patients worldwide.

Putin expressed optimism about the advancements, stating, “We have come very close to the creation of so-called cancer vaccines and immunomodulatory drugs of a new generation.” He expressed hope that these treatments would be utilized effectively as individual therapy methods in the near future.

While Putin did not specify the types of cancer the vaccines would target or the exact mechanisms involved, the announcement signifies a significant step forward in cancer research.

Various countries and companies are actively involved in cancer vaccine development. For instance, the UK government recently partnered with BioNTech to conduct clinical trials for personalized cancer treatments, aiming to reach 10,000 patients by 2030.

Pharmaceutical giants Moderna and Merck & Co are also working on experimental cancer vaccines, with promising mid-stage study results showing efficacy in reducing the chance of recurrence or death from melanoma, a deadly form of skin cancer.

Additionally, existing vaccines against human papillomaviruses (HPV), which can cause various cancers including cervical cancer, as well as vaccines against hepatitis B (HBV), which is linked to liver cancer, are already available.

Russia’s previous success with the development and distribution of the Sputnik V vaccine for COVID-19 demonstrates its capability in vaccine development. Despite initial public reluctance, Putin’s endorsement of the vaccine by personally taking it aimed to reassure the population of its safety and efficacy.

x





Leave a Reply

Your email address will not be published. Required fields are marked *